1) Foulds, G., Shepard, R. M. & Johnson, R. B.: The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother., 25 (Suppl. A): 73-82, 1990.
2) Baldwin, D. R., Wise, R., Andrews, J. M., Ashby, J. P. & Honeybourne, D.: Azithromycin concentrations at the sites of pulmonary infection. Eur. Respir. J., 3: 886-890, 1990.
3) Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L. & Mason, R.: Spectrum and mode of action of aithromycin (CP62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob. Agents Chemother., 31: 1939-1947, 1987.
4) Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C., Mcdonald, J. & Fernandes, P. B.: Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob. Agents Chemother., 32: 1710-1719, 1988.
5) Rylander, M. & Hallander, H. O.: In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and new macrolide, CP-62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticurn. Scand. J. Infect. Dis., Suppl. 53: 12-17, 1988.